These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system. Scheen AJ Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153 [TBL] [Abstract][Full Text] [Related]
4. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Merlotti C; Morabito A; Pontiroli AE Diabetes Obes Metab; 2014 Aug; 16(8):719-27. PubMed ID: 24476122 [TBL] [Abstract][Full Text] [Related]
5. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action. Grams J; Garvey WT Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223 [TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of type 2 diabetes prevention programmes: Markov model of low- and high-intensity lifestyle programmes and metformin in participants with different categories of intermediate hyperglycaemia. Roberts S; Craig D; Adler A; McPherson K; Greenhalgh T BMC Med; 2018 Jan; 16(1):16. PubMed ID: 29378576 [TBL] [Abstract][Full Text] [Related]
7. Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures. Liberopoulos EN; Tsouli S; Mikhailidis DP; Elisaf MS Curr Drug Targets; 2006 Feb; 7(2):211-28. PubMed ID: 16475962 [TBL] [Abstract][Full Text] [Related]
8. Relevance of weight in the management of patients with type 2 diabetes mellitus: towards an adipocentric approach to diabetes. Gorgojo Martínez JJ Med Clin (Barc); 2016 Nov; 147 Suppl 1():8-16. PubMed ID: 28760227 [TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE; Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451 [TBL] [Abstract][Full Text] [Related]
12. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]. Flórez H Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072 [TBL] [Abstract][Full Text] [Related]
13. The prevention of type 2 diabetes: what is the evidence? Chiasson JL; Brindisi MC; Rabasa-Lhoret R Minerva Endocrinol; 2005 Sep; 30(3):179-91. PubMed ID: 16208307 [TBL] [Abstract][Full Text] [Related]
14. Preservation of β-cell function: the key to diabetes prevention. DeFronzo RA; Abdul-Ghani MA J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254 [TBL] [Abstract][Full Text] [Related]
15. Reflecting on type 2 diabetes prevention: more questions than answers! Rosenstock J Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541 [TBL] [Abstract][Full Text] [Related]
16. What are the pharmacotherapy options for treating prediabetes? Daniele G; Abdul-Ghani M; DeFronzo RA Expert Opin Pharmacother; 2014 Oct; 15(14):2003-18. PubMed ID: 25139488 [TBL] [Abstract][Full Text] [Related]
18. The role of bariatric surgery to treat diabetes: current challenges and perspectives. Koliaki C; Liatis S; le Roux CW; Kokkinos A BMC Endocr Disord; 2017 Aug; 17(1):50. PubMed ID: 28797248 [TBL] [Abstract][Full Text] [Related]
19. Diabetes prevention: is there more to it than lifestyle changes? Gruber A; Nasser K; Smith R; Sharma JC; Thomson GA Int J Clin Pract; 2006 May; 60(5):590-4. PubMed ID: 16700860 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological and surgical intervention for the prevention of diabetes. Chiasson JL Nestle Nutr Workshop Ser Clin Perform Programme; 2006; 11():31-42. PubMed ID: 16820729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]